Coptisine
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Coptisine
- DrugBank Accession Number
- DB19308
- Background
Not Available
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 320.323
Monoisotopic: 320.091734355 - Chemical Formula
- C19H14NO4
- Synonyms
- 6,7-dihydrobis(1,3)benzodioxolo(5,6-a:4',5'-g)quinolizinium
- 7,8,13,13a-tetradehydro-2,3:9,10-bismethylenedioxyberbinium
- Alkaloid a, from coptis groenlandica
- Berbinium, 7,8,13,13a-tetradehydro-2,3:9,10-bis(methylenedioxy)-
- Bis(1,3)benzodioxolo(5,6-a:4',5'-g)quinolizinium, 6,7-dihydro-
- Bis(methylenedioxy)protoberberine
- Coptisin
- External IDs
- YHL II
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 0GCL71VN14
- CAS number
- 3486-66-6
- InChI Key
- XYHOBCMEDLZUMP-UHFFFAOYSA-N
- InChI
- InChI=1S/C19H14NO4/c1-2-16-19(24-10-21-16)14-8-20-4-3-12-6-17-18(23-9-22-17)7-13(12)15(20)5-11(1)14/h1-2,5-8H,3-4,9-10H2/q+1
- IUPAC Name
- SMILES
- C1OC2=CC3=C(C=C2O1)C1=[N+](CC3)C=C2C3=C(OCO3)C=CC2=C1
References
- General References
- Not Available
- External Links
- KEGG Compound
- C16938
- ChemSpider
- 65268
- BindingDB
- 50030257
- ChEBI
- 67862
- ChEMBL
- CHEMBL362071
- ZINC
- ZINC000001709414
- PharmGKB
- PA166153416
- PDBe Ligand
- KPT
- Wikipedia
- Coptisine
- PDB Entries
- 4d9x / 4l5k / 4p1d / 7x8o
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at July 26, 2024 17:21 / Updated at July 27, 2024 07:23